Consideration with “Intratumoral gene therapy versus intravenous gene therapy for distant metastasis control with DDMC non-viral vector–p53”

Detalles Bibliográficos
Autores principales: Onishi, Y., Zarogoulidis, P., Ji, R-C, Onishi, M., Kubota, N., Eshita, Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
News
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8505222/
https://www.ncbi.nlm.nih.gov/pubmed/34635820
http://dx.doi.org/10.1038/s41434-021-00298-y
_version_ 1784581486152777728
author Onishi, Y.
Zarogoulidis, P.
Ji, R-C
Onishi, M.
Kubota, N.
Eshita, Y.
author_facet Onishi, Y.
Zarogoulidis, P.
Ji, R-C
Onishi, M.
Kubota, N.
Eshita, Y.
author_sort Onishi, Y.
collection PubMed
description
format Online
Article
Text
id pubmed-8505222
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-85052222021-10-12 Consideration with “Intratumoral gene therapy versus intravenous gene therapy for distant metastasis control with DDMC non-viral vector–p53” Onishi, Y. Zarogoulidis, P. Ji, R-C Onishi, M. Kubota, N. Eshita, Y. Gene Ther News Nature Publishing Group UK 2021-10-12 2022 /pmc/articles/PMC8505222/ /pubmed/34635820 http://dx.doi.org/10.1038/s41434-021-00298-y Text en © The Author(s), under exclusive licence to Springer Nature Limited 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle News
Onishi, Y.
Zarogoulidis, P.
Ji, R-C
Onishi, M.
Kubota, N.
Eshita, Y.
Consideration with “Intratumoral gene therapy versus intravenous gene therapy for distant metastasis control with DDMC non-viral vector–p53”
title Consideration with “Intratumoral gene therapy versus intravenous gene therapy for distant metastasis control with DDMC non-viral vector–p53”
title_full Consideration with “Intratumoral gene therapy versus intravenous gene therapy for distant metastasis control with DDMC non-viral vector–p53”
title_fullStr Consideration with “Intratumoral gene therapy versus intravenous gene therapy for distant metastasis control with DDMC non-viral vector–p53”
title_full_unstemmed Consideration with “Intratumoral gene therapy versus intravenous gene therapy for distant metastasis control with DDMC non-viral vector–p53”
title_short Consideration with “Intratumoral gene therapy versus intravenous gene therapy for distant metastasis control with DDMC non-viral vector–p53”
title_sort consideration with “intratumoral gene therapy versus intravenous gene therapy for distant metastasis control with ddmc non-viral vector–p53”
topic News
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8505222/
https://www.ncbi.nlm.nih.gov/pubmed/34635820
http://dx.doi.org/10.1038/s41434-021-00298-y
work_keys_str_mv AT onishiy considerationwithintratumoralgenetherapyversusintravenousgenetherapyfordistantmetastasiscontrolwithddmcnonviralvectorp53
AT zarogoulidisp considerationwithintratumoralgenetherapyversusintravenousgenetherapyfordistantmetastasiscontrolwithddmcnonviralvectorp53
AT jirc considerationwithintratumoralgenetherapyversusintravenousgenetherapyfordistantmetastasiscontrolwithddmcnonviralvectorp53
AT onishim considerationwithintratumoralgenetherapyversusintravenousgenetherapyfordistantmetastasiscontrolwithddmcnonviralvectorp53
AT kubotan considerationwithintratumoralgenetherapyversusintravenousgenetherapyfordistantmetastasiscontrolwithddmcnonviralvectorp53
AT eshitay considerationwithintratumoralgenetherapyversusintravenousgenetherapyfordistantmetastasiscontrolwithddmcnonviralvectorp53

Ejemplares similares